M.I.TECH Co.Ltd (179290) - Cash Flow Conversion Efficiency
Based on the latest financial reports, M.I.TECH Co.Ltd (179290) has a cash flow conversion efficiency ratio of 0.047x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.62 Billion ≈ $3.81 Million USD) by net assets (₩120.80 Billion ≈ $81.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See M.I.TECH Co.Ltd balance sheet independence to measure how much of total assets are equity-financed.
M.I.TECH Co.Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how M.I.TECH Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 179290 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
M.I.TECH Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of M.I.TECH Co.Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
I-Berhad
KLSE:4251
|
0.032x |
|
Carnaby Resources Ltd
AU:CNB
|
-0.074x |
|
SHANGHAI FUDAN H YC-,10
F:FDY
|
N/A |
|
PT Janu Putra Sejahtera Tbk
JK:AYAM
|
0.017x |
|
Arcticzymes Technologies ASA
OL:AZT
|
0.026x |
|
UNICOMMERCE ESOLUTIONS LIMITED
NSE:UNIECOM
|
0.154x |
|
Hillevax Inc
NASDAQ:HLVX
|
-0.005x |
|
Cj Corp Pref
KO:001045
|
0.099x |
Annual Cash Flow Conversion Efficiency for M.I.TECH Co.Ltd (2015–2024)
The table below shows the annual cash flow conversion efficiency of M.I.TECH Co.Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see M.I.TECH Co.Ltd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩108.83 Billion ≈ $73.75 Million |
₩23.66 Billion ≈ $16.04 Million |
0.217x | +13.48% |
| 2023-12-31 | ₩92.94 Billion ≈ $62.98 Million |
₩17.81 Billion ≈ $12.07 Million |
0.192x | +86.33% |
| 2022-12-31 | ₩83.55 Billion ≈ $56.62 Million |
₩8.59 Billion ≈ $5.82 Million |
0.103x | -59.70% |
| 2021-12-31 | ₩64.76 Billion ≈ $43.89 Million |
₩16.52 Billion ≈ $11.20 Million |
0.255x | +262.09% |
| 2020-12-31 | ₩55.40 Billion ≈ $37.55 Million |
₩3.90 Billion ≈ $2.65 Million |
0.070x | +9.45% |
| 2019-12-31 | ₩48.25 Billion ≈ $32.70 Million |
₩3.11 Billion ≈ $2.11 Million |
0.064x | +41.35% |
| 2018-12-31 | ₩44.77 Billion ≈ $30.34 Million |
₩2.04 Billion ≈ $1.38 Million |
0.046x | -11.71% |
| 2017-12-31 | ₩18.67 Billion ≈ $12.66 Million |
₩963.43 Million ≈ $652.90K |
0.052x | -69.14% |
| 2016-12-31 | ₩16.63 Billion ≈ $11.27 Million |
₩2.78 Billion ≈ $1.88 Million |
0.167x | +462.76% |
| 2015-12-31 | ₩14.71 Billion ≈ $9.97 Million |
₩-677.68 Million ≈ $-459.25K |
-0.046x | -- |
About M.I.TECH Co.Ltd
M.I.TECH Co.,Ltd engages in the provision of various medical devices in South Korea. The company offers HANAROSTENT, a non-vascular stent; and glucometers under the GBIO BASE and RAPICHECK brand names. It also provides beauty systems, such as BRT system which is used in cleansing skin and inject the effective component in non-invasive way; and ClearView which is used in injecting the effective co… Read more